Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This project aims to investigate the practicality and utility of home-based high-intensity interval training (HIIT) by undertaking a previously developed, novel home-based HIIT intervention for people with Parkinson's (PwP).
This is a randomised controlled feasibility study with mechanistic, physiological and clinical sub components.
Participants will be undertaking a 12-week home-based high-intensity interval training intervention. The programme is a feasibility study, previously co-created by people with Parkinson's and clinicians within an iterative planning process of focus groups and exercise testing.
Following recruitment, participants will undertake initial baseline assessments. These will involve collection of anthropometric measurements and general lifestyle and Parkinson's related information, followed by pre-intervention mechanistic, physiological and clinical outcome measures. Participants will then be randomised to the HIIT intervention, or usual care control group.
Both groups will then undertake 7 days pre-intervention physical activity monitoring following accelerometer instruction, as a baseline measure of habitual physical activity (an important confounding variable).
Following an initial home visit, participants will then undertake a 12-week high-intensity interval training programme in the home setting, with supplied exercise equipment including music and exercise prompts, and remote support and online resources. Participants will complete a 32 minute training session 3 times per week, with at least one day of rest between sessions. Participants will be loaned heart rate monitoring devices, which will remotely record heart rate per exercise session. During week 7 of the intervention, participants will be asked to repeat 7 days of accelerometer wearing to compare habitual physical activity. Participants will record feasibility and safety aspects such as HIIT participation / adverse effects and events / exercise adaptations in diaries during the course of the intervention.
Participants will then undergo post-intervention outcome measures. Participants will also be asked to be involved in a 45-minute post intervention focus group as part of a process evaluation. Depending on numbers, it is likely that there will be 2 of these parallel groups.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exercise | Experimental | High-intensity interval training plus usual care |
|
| Usual care | No Intervention | Usual care / treatment. Usual physical activity. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| High-intensity interval training | Other | 12-weeks of high intensity interval exercise, 30 minutes thrice weekly |
|
| Measure | Description | Time Frame |
|---|---|---|
| Programme completion | Number of weeks of exercise programme completed, self administered | Through study completion, an average of 12 weeks |
| Programme adherence | Number of exercise sessions completed in full, self administered | Through study completion, an average of 12 weeks |
| Change from baseline brain derived neurotrophic factor (BDNF) | Blood sample: Brain-derived neurotrophic factor (pg/ml) | 1 week before first exercise session and 1 day after last session. |
| Change from baseline Relative VO2max | Maximal oxygen uptake (ml/min/kg) incremental exercise test | 1 week before first exercise session and 1 day after last session. |
| Measure | Description | Time Frame |
|---|---|---|
| Adverse effects and events | Adverse effects and events related to exercise sessions, self administered | Through study completion, an average of 12 weeks |
| Change from baseline 30 second sit to stand test |
| Measure | Description | Time Frame |
|---|---|---|
| Total weekly habitual physical activity | Weekly physical activity (minutes) measured with accelerometer, self administered | 1 week prior to start of exercise programme after baseline assessments |
| Total weekly habitual physical activity |
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospitals Plymouth NHS Trust | Plymouth | Devon | PL68DH | United Kingdom |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40661734 | Derived | Harpham C, Gunn H, Marsden J, Bescos-Garcia R, Murgatroyd C, Connolly L. Home-Based High-Intensity Interval Training for People With Parkinson's: A Randomized, Controlled, Feasibility Trial. Health Sci Rep. 2025 Jul 14;8(7):e71024. doi: 10.1002/hsr2.71024. eCollection 2025 Jul. |
Not provided
Not provided
Not provided
De-identified data will be available for a period of 10 years in line with University of Plymouth policy
On request
Not provided
Not provided
| ID | Term |
|---|---|
| D010300 | Parkinson Disease |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D020734 | Parkinsonian Disorders |
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000072696 | High-Intensity Interval Training |
| ID | Term |
|---|---|
| D064797 | Physical Conditioning, Human |
| D015444 | Exercise |
| D009043 | Motor Activity |
| D009068 | Movement |
Not provided
Not provided
Randomised controlled feasibility study with mechanistic, physiological and clinical sub components
Not provided
Not provided
Assessor blinded to group allocation
Number of times standing in 30 seconds
| 1 week before first exercise session and 1 day after last session. |
| Oxford Participation Activities Questionnaire | Participant administered lifestyle questionnaire | 1 week before first exercise session and 1 day after last session |
| Change from baseline Movement Disorder Society Unified Parkinson's Disease Rating Scale part 3 | Motor examination, minimum score 0, maximum score 76, higher scores indicate increased disease severity | 1 week before first exercise session and 1 day after last session. |
| Exercise intensity | Achieved exercise intensity (% of maximum heart rate), self administered | Through study completion, an average of 12 weeks |
Weekly physical activity (minutes) measured with accelerometer, self administered
| During week 7 of the exercise programme |
| Maximum heart rate | Beats per minute, to be measured during VO2max assessment | 1 week before first exercise session |
| Height | Height (centimetres) with stadiometer | 1 week before first exercise session |
| Weight | Weight (kilograms) with calibrated digital scales | 1 week before first exercise session |
| Lifestyle data questionnaire | 10-item basic lifestyle data bespoke questionnaire | 1 week before first exercise session |
| Health screening questionnaire | Screening for health issues that may prevent participation | 1 week before first exercise session at baseline assessments |
| D009422 | Nervous System Diseases |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |
| D001519 | Behavior |
| D009142 |
| Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |